Previously published guidelines for the diagnosis and management of primary immune
thrombocytopenia (ITP) require updating largely due to the introduction of new classes of …

Over the last decade, there have been numerous developments and changes in treatment
practices for the management of patients with immune thrombocytopenia (ITP). This article is …

Immune thrombocytopenia (ITP) is commonly encountered in clinical practice. In 1996 the
American Society of Hematology published a landmark guidance paper designed to assist …

Immune thrombocytopenic purpura (ITP) is an autoimmune condition that affects nearly 1:
10,000 people in the world. It is traditionally defined by a platelet count of less than 100 x …

Primary immune thrombocytopenia is an autoimmune disorder of unknown cause affecting
both children and adults. The low peripheral blood platelet count is caused by premature …

Abstract In 1996 and 2011, the American Society of Hematology (ASH) supported efforts to
create guidelines for the diagnosis and management of patients with immune …

Background Immune thrombocytopenia (ITP) is a heterogeneous acquired disorder
characterized by isolated thrombocytopenia whose exact pathogenesis is not yet clear …

Immune thrombocytopenia (ITP) comprises a syndrome of diverse disorders that have in
common immune‐mediated thrombocytopenia, but that differ with respect to pathogenesis …

Immune thrombocytopenia, or ITP, has been recognized as a clinical entity for centuries, and
the importance of humoral mechanisms in the pathophysiology of ITP has been recognized …

Primary immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized
by isolated thrombocytopenia caused by increased platelet destruction and impaired platelet …